brineura and cln2 disease
Published 4 years ago • 142 plays • Length 3:25Download video MP4
Download video MP3
Similar videos
-
1:06
safety analysis of the bcl-2 inhibitor venetoclax for cll
-
2:08
cliff 2 min biologics
-
1:05
dr. baz on selinexor in multiple myeloma
-
1:42
venetoclax resistance and alternative treatments in cll
-
![malonodiserinolamide-derivatized [60]fullerene in breast adenocarcinoma – video s3 [id 138641]](https://i.ytimg.com/vi/NMAuX6J7Be0/mqdefault.jpg)
0:21
malonodiserinolamide-derivatized [60]fullerene in breast adenocarcinoma – video s3 [id 138641]
-
0:57
dr. visco on the utility of bendamustine in mcl
-
0:53
biosimilar rituximab in the treatment of cll
-
1:28
clinical management of venetoclax in multiple myeloma
-
1:12
pirtobrutinib vs nemtabrutinib in cll
-
2:24
are biosimilars as efficacious as their reference drugs?
-
5:29
first- and second-line treatments for locally advanced renal cell carcinoma
-
1:16
preliminary results of ibruntinib in combination with fcr chemotherapy for cll
-
2:23
considering additional molecular testing for cll
-
5:43
case 2: mrd testing in cll
-
3:19
an update on two trials evaluating venetoclax in subsets of cll
-
2:43
resistance mechanisms of current treatments in cll
-
1:18
an overview of a study combining nivolumab with ibrutinib in cll and richter transformation
-
3:02
combined ibrutinib and venetoclax in patients with treatment-naïve high-risk cll